Radiopharmaceuticals represent a promising new frontier in cancer therapy. In the United States, cancer is the second leading cause of death. There is an urgent need to develop new therapies to meet ...

The second Society of Nuclear Medicine and Molecular Imaging (SNMMI) AI Summit, organized by the SNMMI AI Task Force, took ...

This study was performed in accordance with and approved by the Animal Care and Use Committee of RIKEN Kobe Institute (MAH18-02). Adult male C57BL/6J mice (8–10 wk old) were purchased from Clea Japan ...

Incidental findings from PET are common, induce unnecessary patient anxiety, and incur substantial costs to the health care system, with further diagnostic clarification potentially delaying important ...

Recently, a collaborative effort among research centers in the United States and Europe resulted in the development of ...

Fibroblast activation protein (FAP) is highly expressed in many cancers, especially sarcomas, and represents a promising theranostic target. We present an updated retrospective analysis of 90Y-FAP ...

You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...

Coronary heart disease is a leading cause of death in the United States and the most prevalent form of cardiovascular disease, affecting 16 million people. Gated SPECT cardiac perfusion imaging plays ...

Journal of Nuclear Medicine February 2026, jnumed.125.270083; DOI: https://doi.org/10.2967/jnumed.125.270083 ...